Bullboard - Stock Discussion Forum SCYNEXIS Inc SCYX

Healthcare Biotechnology

SCYNEXIS, Inc. is a biotechnology company. It is pioneering medicine to overcome and prevent difficult-to-treat and drug-resistant infections. It develops antifungal platform fungerps, a novel class of antifungal agents called triterpenoids, that are structurally distinct glucan synthase inhibitors and have generally shown in vitro and in vivo activity against a range of human fungal pathogens,... see more

Add To Watchlist

NDAQ:SCYX - Post Discussion

SCYNEXIS Inc > 2 Weeks Left...

View:

Post by JonathanJSmith on May 17, 2021 11:23am

2 Weeks Left...

Only two weeks before a decision is made on Ibrexa. Hmmm, could be quite a windfall if approved. Time to roll the dice! ;)

Cheers,

JJ

Comment

Comment by Kipper22 on Jun 02, 2021 4:58am

Wasn't the FDA supposed to deliver their verdict yesterday?

Comment

Comment by JonathanJSmith on Jun 02, 2021 7:26am

Yeah, everyone's in waiting mode. I think the company has 24 hours to release material information - assuming they've received some. Personally, based on data the drug should be approved. My only concern is the vexing "we couldn't inspect the manufacturing site(s) due to Covid-19 travel restrictions" comment; if such comment is forthcoming, the company could be looking at ...more

Comment

SCYNEXIS Inc